CEVAXIN is present at the 41st Annual Meeting of the European Society for Pediatric Infectious Diseases (ESPID 2023) taking place in Lisbon, Portugal, with a poster on the use of mobile technology for vaccine pharmacovigilance reporting in Panama, funded by Senacyt and with the collaboration of several notable Panamanian scientists, such as Dr. Rodrigo DeAntonio (Executive Director and scientist at CEVAXIN), Dr. Xavier Sáez Llorens, Dr. Gabriel Rebollón, among others. Rodrigo DeAntonio (Executive and Scientific Director at CEVAXIN), Dr. Xavier Sáez Llorens, Dr. Gabriel Rebollón, among others.


ESPID is the world's premier meeting on pediatric infectious diseases, bringing together top researchers and world-renowned clinicians in a multifaceted program covering clinical areas, epidemiology, public health, microbiology, immunology, host-pathogen interactions, genomics and their interfaces, highlighting the most recent advances and also where breakthroughs have been most challenging.